Physician profile
Diana Burda
NPI 1083631543
$6,810.57
in general payments reported to CMS, 2019-2025
37 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,001 · 2020: $404 · 2021: $87.00 · 2022: $1,103 · 2023: $898 · 2024: $869 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,214.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $877.79 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $625.62 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $603.69 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Lilly USA, LLC | $529.90 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $492.08 | 2019-2025 | |
| Amgen INC. | $491.22 | 2019-2025 | Evenity |
| Janssen Pharmaceuticals, INC | $306.07 | 2019-2025 | Spravato |
| Amarin Pharma, INC. | $257.56 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.12 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $192.68 | 2019-2025 | Xifaxan, Trulance |
| Allergan, INC. | $186.77 | 2019 | |
| Abbvie INC. | $170.23 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $151.51 | 2019-2025 | Eliquis, Camzyos |
| Nestle Healthcare Nutrition INC. | $147.64 | 2022 | |
| Mylan Specialty L.P. | $137.70 | 2019-2024 | Yupelri |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Burda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.